Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

CellVoyant, an AI-first biotech based in Bristol UK,  today launches FateView™, the first online predictive cell analytics platform designed to help cell-based therapeutic drug developers reduce costs ...

Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Plant regeneration relies on a delicate balance between stem cell renewal and differentiation, yet the evolutionary origin ...

Maxwell has officially signed a full-line supply contract for Perovskite/SHJ tandem cells with a Chinese new energy company, ...

Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic ...